Menu

Blog

Archive for the ‘biotech/medical’ category: Page 813

Oct 24, 2022

Engineered protein calms immune cells to prevent autoimmune diseases

Posted by in categories: biotech/medical, neuroscience

Our immune system is the first line of defense against disease, but unfortunately it can go rogue and attack healthy tissues. Scientists at Johns Hopkins University have now engineered a protein that may help prevent these autoimmune diseases by boosting the number of regulatory T cells (Tregs).

The immune system keeps a vigilant watch over our bodies at all times, tagging and destroying foreign pathogens or problematic cells to prevent illness. However, sometimes it can get a little overzealous and start attacking the body’s own cells, which can trigger a range of autoimmune diseases like type 1 diabetes, lupus and rheumatoid arthritis.

To prevent these issues from arising, immune cells called Tregs play the vital role of keeping the immune system responses in check, but they can fail at this job. So for the new study, the researchers set out to boost their numbers, following previous studies that have shown promise in doing so to help treat autoimmune diseases like multiple sclerosis and Crohn’s disease.

Oct 24, 2022

Novartis seals deal to license high-priced cancer drug

Posted by in category: biotech/medical

The deal, which was formally signed on the sidelines of the World Cancer Congress in Geneva this week, marks the first time a pharmaceutical company is making a patented cancer medicine available through a voluntary licensing scheme. “This is important because it’s the first and helps show that voluntary licences can work for cancer drugs,” Charles Gore, the executive director of the Medicines Patent Pool (MPP), told SWI swissinfo.ch.


Swiss pharma giant Novartis has finalised a deal to allow generic production of its patented drug nilotinib to treat chronic myeloid leukemia.

Oct 24, 2022

Research Deep Dive

Posted by in categories: biotech/medical, robotics/AI

Join Pattie Maes, Andy Lippman, and a host of special guests and Media Lab researchers for a deep dive into generative artificial intelligence—the use of deep learning and large data sets to produce text, sound, images, movies, 3D designs, virtual characters, even proteins and drug candidates.

This discussion will be livestreamed, and no registration is required; it will be embedded on this page before the presentations begin. The livestream will be closed-captioned, and the archived video will be posted with closed captions within a few days of the event.

Oct 24, 2022

Hybrid Intelligence: Coupling AI and the Human Brain | Edward Boyden bigthink

Posted by in categories: biotech/medical, finance, military, mobile phones, robotics/AI

Edward Boyden is a Hertz Foundation Fellow and recipient of the prestigious Hertz Foundation Grant for graduate study in the applications of the physical, biological and engineering sciences. A professor of Biological Engineering and Brain and Cognitive Sciences at MIT, Edward Boyden explains how humanity is only at its infancy in merging with machines. His work is leading him towards the development of a “brain co-processor”, a device that interacts intimately with the brain to upload and download information to and from it, augmenting human capabilities in memory storage, decision making, and cognition. The first step, however, is understanding the brain on a much deeper level. With the support of the Fannie and John Hertz Foundation, Ed Boyden pursued a PhD in neurosciences from Stanford University.

The Hertz Foundation mission is to provide unique financial and fellowship support to the nation’s most remarkable PhD students in the hard sciences. Hertz Fellowships are among the most prestigious in the world, and the foundation has invested over $200 million in Hertz Fellows since 1963 (present value) and supported over 1,100 brilliant and creative young scientists, who have gone on to become Nobel laureates, high-ranking military personnel, astronauts, inventors, Silicon Valley leaders, and tenured university professors. For more information, visit hertzfoundation.org.

Continue reading “Hybrid Intelligence: Coupling AI and the Human Brain | Edward Boyden bigthink” »

Oct 24, 2022

Hevolution Foundation Launches Grants Program to Encourage Research into the Science of Aging in Saudi Arabia

Posted by in categories: biotech/medical, business, life extension, science

RIYADH, Saudi Arabia—()— Hevolution Foundation, a non-profit organization that provides grants and early-stage investments to incentivize research and entrepreneurship in healthspan science, announces a new grants program to encourage research into the aging process in Saudi Arabia, as part of the growing Saudi scientific ecosystem. The program, Hevolution’s Open Call for Grant Applications in Saudi Arabia, will provide funding of up to 500,000 Saudi Riyals for local researchers with an interest in the mechanisms of aging.

“This grants program is the first of many through which we aim to encourage the development of the field of aging research in Saudi Arabia” Tweet this

“Saudi Arabia’s population is relatively young but has high rates of age-related conditions such as heart disease and diabetes,” commented Mehmood Khan, MD, Hevolution Foundation’s Chief Executive Officer. “Our hope is that by tackling the aging process itself, we can alleviate the burden of diseases and conditions of aging for the people of Saudi Arabia and worldwide. With this pilot program and others that we have in the works, we hope to enable Saudi Arabia’s scientific community to be a key player in the global charge to reduce the burden of age-related diseases and conditions that affect most of humanity.”

Oct 24, 2022

David Sinclair at ARDD2022: Great release of unpublished data from David Sinclair’s Lab

Posted by in categories: biotech/medical, internet, life extension

The Aging and Drug Discovery Conference (ARDD) 2022 is pleased to present David Sinclair from Harvard Medical School, who shares new unpublished results from his lab at Harvard Medical School.

Held in Copenhagen at the glorious Ceremonial Hall, this meeting gathers the most prominent figures of the aging and longevity research field, from scientists to clinicians, investors, developers, and everything in between. The fast growth of the conference is evidence of its great quality. In 2022 we had around 400 people on-site, and many others joined through the web.

Continue reading “David Sinclair at ARDD2022: Great release of unpublished data from David Sinclair’s Lab” »

Oct 24, 2022

Rejuvenation Startup Summit 2022 started to publish videos of selected talks

Posted by in categories: biotech/medical, finance, life extension

The Inaugural Rejuvenation Startup Summit 2022, brought to you by the Forever Healthy Foundation, took place with over 400 participants from over 30 countries in October. It is a vibrant networking event that aims to accelerate the development of the rejuvenation biotech industry. The Summit brings together startups, members of the longevity venture capital / investor ecosystem, and researchers interested in founding or joining a startup – all aiming to create therapies to vastly extend the healthy human lifespan. We started to publish videos with a first set of selected speakers on the 2022 summit:

Oct 24, 2022

Reason | An 80/20 Gene Therapy that Just Works — Challenge

Posted by in categories: biotech/medical, computing, life extension, nanotechnology

Foresight Biotech & Health Extension Meeting sponsored by 100 Plus Capital.
Program & apply to join: https://foresight.org/biotech-health-extension-program/

This video was recorded at the Foresight Longevity Workshop.

Continue reading “Reason | An 80/20 Gene Therapy that Just Works — Challenge” »

Oct 24, 2022

A pro-oxidant combination of resveratrol and copper down-regulates multiple biological hallmarks of ageing and neurodegeneration in mice

Posted by in categories: biotech/medical, life extension

ROS are short lived molecular species containing an unpaired electron which makes them highly reactive as they search for another electron to pair with, and in the process can damage biomolecules such as DNA, proteins and lipids54. ROS induced oxidative stress is known to have multiple deleterious effects on host cells55. However, we have reported that, paradoxically, when ROS is artificially generated outside the cell in the extracellular spaces of the body, they can have wide ranging therapeutic effects18,19,20,26,27. Admixing R with Cu leads to generation of oxygen radicals by virtue of the ability of R to reduce Cu (II) to Cu (I)23,25. Oxygen radicals that are generated in the stomach upon oral administration of R–Cu are apparently absorbed to have systemic effects in the form of deactivation/eradication of extracellular cfChPs. We have shown that cfChPs have wide-ranging damaging effects on host cells. For example, cfChPs can readily enter into the healthy cells to damage their DNA, activate inflammatory cytokines and promote apoptosis via the mitochondrial pathway13,14. Given that 1 × 109–1 × 1012 cells die in the body every day56,57, we have hypothesised that repeated and lifelong assault on healthy cells by cfChPs derived from the dying cells may be the underlying cause of ageing15,16. In support of this hypothesis we show in this article that prolonged oral administration of R–Cu to ageing mice down-regulated multiple biological hallmarks of ageing and neurodegeneration by virtue of its ability to deactivate cfChPs. Our results suggest that R–Cu may qualify as an ideal anti-ageing agent since it has the potential to simultaneously retard or delay the many conditions that are associated with ageing2. To be globally applicable, an ideal anti-ageing agent should also be inexpensive and non-toxic—the two criteria that are also met by R–Cu. The latter can be easily administered orally, and both R and Cu are already approved for human use. An illustrated summary of the study design and the mechanisms by which R–Cu generated oxygen radicals eradicate cfChPs from brain micro-environment leading to down-regulation of ageing hallmarks is provided in Fig. 10.

The mechanism(s) by which R–Cu down-regulates the multiple biological hallmarks of ageing and neurodegeneration needs elaboration. Reversal of telomere shortening by R–Cu may suggest that telomere shortening could be a consequence of DNA damage inflicted by cfChPs which shear off telomere ends causing them to shorten. We observed differential effects between female and male mice with respect to telomere abnormalities. R–Cu effects in preventing telomere abnormalities in female mice were statistically significant for all parameters tested, while this was not the case in male mice. The biological explanation for this discrepant finding remains to be determined. Breakage of telomere ends may also help to explain our detection of persistent γ-H2AX signals in telomere regions of brain cells (DNA-SCARS)—an established signature of senescence43. The bare chromosomal ends can fuse with each other to lead to chromosomal instability and aneuploidy48, as was detected in our study.

Oct 23, 2022

Not Science Fiction: Methane-Eating “Borgs” Have Been Assimilating Earth’s Microbes

Posted by in categories: biotech/medical, genetics

A newly discovered type of transferable DNA

DNA, or deoxyribonucleic acid, is a molecule composed of two long strands of nucleotides that coil around each other to form a double helix. It is the hereditary material in humans and almost all other organisms that carries genetic instructions for development, functioning, growth, and reproduction. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

Page 813 of 2,683First810811812813814815816817Last